Sponsor Pipeline

Guangdong Ruishun Biotech Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06314828 A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or… B-cell Non-Hodgkin's Lymphoma Not Yet Recruiting
NCT06340490 A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE) Systemic Lupus Erythematosus Not Yet Recruiting
NCT06894693 A Phase I Clinical Trial of RS001 in Patients with Relapsed/Refractory B-Cell Malignancies B-cell Non-Hodgkin's Lymphoma Not Yet Recruiting
Disease Areas
Lupus (SLE) (1) Leukemia (1) Acute Lymphoblastic Leukemia (ALL) (1)
Get alerts when Guangdong Ruishun Biotech Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free